A unique subset of epithelial ovarian cancers with platinum sensitivity and PARP inhibitor resistance. [electronic resource]
Producer: 20150413Description: 628-34 p. digitalISSN:- 1538-7445
- BRCA1 Protein -- genetics
- BRCA2 Protein -- genetics
- Carboplatin -- administration & dosage
- Carcinoma, Ovarian Epithelial
- Cisplatin -- administration & dosage
- DNA Breaks, Double-Stranded -- drug effects
- DNA Repair -- genetics
- Disease-Free Survival
- Drug Resistance, Neoplasm -- genetics
- Enzyme Inhibitors -- administration & dosage
- Female
- Humans
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Poly(ADP-ribose) Polymerase Inhibitors
- Poly(ADP-ribose) Polymerases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.